NovoCure Ltd — Director's Dealing 2019

Jul 2, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NovoCure Ltd (NVCR)
CIK: 0001645113
Period of Report: 2019-06-28

Reporting Person: Danziger Asaf (Director, Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-06-28	Ordinary Shares	M	187500	$7.15	Acquired	445811	Direct
2019-06-28	Ordinary Shares	S	187500	$62.15	Disposed	258311	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-06-28	Options to Buy Ordinary Shares	$7.15	M	187500	Disposed	2027-02-21	Ordinary Shares (187500)	Direct

Footnotes

F1: Transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Danziger.

F2: Fully vested and currently exercisable as of the date hereof.